Related Experiment Video
Updated: Jun 12, 2026

A Colorimetric Assay that Specifically Measures Granzyme B Proteolytic Activity: Hydrolysis of Boc-Ala-Ala-Asp-S-Bzl
Published on: November 28, 2014
Granzyme A activates another way to die
1Immune Disease Institute and Program in Cellular and Molecular Medicine, Children's Hospital Boston, Harvard Medical School, Boston, MA, USA. lieberman@idi.harvard.edu
Abstract:
Granzyme A (GzmA) is the most abundant serine protease in killer cell cytotoxic granules. GzmA activates a novel programed cell death pathway that begins in the mitochondrion, where cleavage of NDUFS3 in electron transport complex I disrupts mitochondrial metabolism and generates reactive oxygen species (ROS). ROS drives the endoplasmic reticulum-associated SET complex into the nucleus, where it activates single-stranded DNA damage. GzmA also targets other important nuclear proteins for degradation, including histones, the lamins that maintain the nuclear envelope, and several key DNA damage repair proteins (Ku70, PARP-1). Cells that are resistant to the caspases or GzmB by overexpressing bcl-2 family anti-apoptotic proteins or caspase or GzmB protease inhibitors are sensitive to GzmA. By activating multiple cell death pathways, killer cells provide better protection against a variety of intracellular pathogens and tumors. GzmA also has proinflammatory activity; it activates pro-interleukin-1beta and may also have other proinflammatory effects that remain to be elucidated.
Insights
Granzyme A (GzmA) initiates a unique cell death pathway by damaging mitochondria and DNA. This pathway is effective against cells resistant to other death signals, offering enhanced protection.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Granzyme A (GzmA) is a key serine protease found in cytotoxic granules of immune cells.
- GzmA plays a crucial role in cell-mediated cytotoxicity and immune surveillance.
- Understanding GzmA's mechanisms is vital for developing novel therapeutic strategies.
Purpose of the Study:
- To elucidate the novel programmed cell death pathway initiated by Granzyme A.
- To investigate the molecular targets and mechanisms of GzmA-induced cell death.
- To explore GzmA's role in overcoming resistance to other cell death pathways and its proinflammatory effects.
Main Methods:
- Analysis of GzmA's effects on mitochondrial function and cellular metabolism.
- Investigation of GzmA's impact on nuclear proteins and DNA integrity.
- Assessment of cellular sensitivity to GzmA in the context of resistance to caspases or Granzyme B.
Main Results:
- GzmA cleaves NDUFS3 in electron transport complex I, disrupting mitochondrial metabolism and generating reactive oxygen species (ROS).
- ROS facilitates nuclear translocation of the SET complex, leading to single-stranded DNA damage.
- GzmA degrades histones, lamins, and DNA repair proteins (Ku70, PARP-1), inducing cell death.
- Cells resistant to caspases or GzmB are sensitive to GzmA, highlighting its distinct cytotoxic mechanism.
- GzmA exhibits proinflammatory activity by activating pro-interleukin-1beta.
Conclusions:
- GzmA activates a unique, multi-pronged cell death pathway involving mitochondrial dysfunction, ROS generation, and nuclear damage.
- This pathway effectively eliminates cells resistant to conventional apoptotic or cytotoxic mechanisms.
- GzmA's distinct mode of action and proinflammatory potential offer new avenues for therapeutic intervention in cancer and infectious diseases.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Apoptosis
Caspases
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...

